Sample Request Form

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

categories

Allergies
Allergies
July 21, 2018

Preliminary results from INSYS Therapeutics are showing advances in their new intranasal epinephrine, with a similar bioavailability to the popular intramuscular EpiPen. President and CEO of INSYS, Saeed Motahari commented: "Given that epinephrine is on the FDA shortage list, we look forward to working closely with the Agency to determine the optimal path to making this investigational novel drug delivery system available."

Read More →
Allergies
July 21, 2018

Dr. Giselle Mosnaim, Allergist at NorthShore University HealthSystem recommends the use of intranasal steroid sprays, sinus rinses, and oral nasal decongestant tablets to relieve common allergy symptoms, such as sinus headaches.

Read More →